Mylan
Hertraz
HERTRAZ contains Drugs / Molecule called “TRASTUZUMAB”. It is a monoclonal antibody that interferes with the HER/NEU receptor. The HER receptors are proteins that are embedded in the cell membrane and communicate molecular signals from outside the cell to inside the cell. It works by targeting certain tumour cells and stopping them from growing and reproducing.
Indication
Hertraz is used for the treatment of Metastatic Breast Cancer
Note
Precaution
- Hertraz is a prescription drug and should be used under proper medical guidance and advice.
- Hertraz should be avoided during pregnancy and lactation.
Strength
150 mg, 440 mg
Packing
Vial (Single Dose)
Storage
Hertraz should be stored at 2 C to 8 C and should not be frozen.
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Anastronat
CIPLA LTD. (INDIA)
Anastrozole-armotraz
NATCO PHARMA LIMITED (INDIA)
Xtane
CIPLA LTD. (INDIA).
Armotraz
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)